EVISA Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



The Lancet

Description
The Lancet is the world's leading independent general medical journal. The journal's coverage is international in focus and extends to all aspects of human health.

 

Status
active
Indexing
Scopus
Subject

Source type
Book
Publisher
ISBN ISSN
0140-6736
First volume
1
Last volume
379+
Publish city
London
Homepage
Description
The Lancet is published weekly from editorial offices in London and New York. It aims to publish the best original primary research papers, and review articles of the highest standard. The Lancet is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. Drawing on an international network of advisers and contributors, The Lancet meets the needs of physicians by adding to their clinical knowledge and alerting them to current issues affecting the practise of medicine worldwide. The blend of challenging editorials, signed commentaries, original research, commissioned reviews, an international news section, and the views of readers in the letters pages make The Lancet an essential weekly read for physicians all over the world.

The Lancet is available by personal subscription to individual physicians. It is also available by subscription to institutions, libraries, and biomedical companies.











Imprint     Disclaimer

© 2003 - 2024 by European Virtual Institute for Speciation Analysis ( EVISA )